Morgan Joseph reiterates a 'Buy' rating on Spectrum Pharmaceuticals (Nasdaq: SPPI) and price target of $8.

Morgan analyst says, "Expectations ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE